[Clinical pharmacology and therapeutic applications of phenyl 3-dibutylamino-ethylamino 5 oxadiazole (LA 1221)].
D000368:Aged; D000779:Anesthetics, Local; D000818:Animals; D001167:Arteritis / Q000188:drug therapy; D002539:Cerebral Arterial Diseases / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy; D051379:Mice; D008875:Middle Aged; D010069:Oxadiazoles / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity*; D011817:Rabbits; D051381:Rats; D012212:Rheology; D014665:Vasodilator Agents
D000779:Anesthetics, Local; D010069:Oxadiazoles; D014665:Vasodilator Agents
Pharmacologie clinique et applications thérapeutiques du phényl 3-dibutylamino-éthylamino 5 oxadiazole (LA 1221)